HFA Premium Access

Response rate to sacubitril-valsartan in the community. Is there a clear phenotype?

Congress Presentation

About the speaker

Doctor Rebabonye Pharithi

Royal Free London NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

55 more presentations in this session

Small tolerated enalapril doses before ARNI administration predicts adverse events during ARNI up-titration

Speaker: Doctor A. Ntalianis (Athens, GR)

Thumbnail

Prescription of sacubitril/valsartan in a real-world population

Speaker: Mr J. AGOSTINHO (Lisbon, PT)

Thumbnail

Use of sacubitril-valsartan in heart failure with reduced ejection fraction: real world experience

Speaker: Doctor F. Ferreira (Lisbon, PT)

Thumbnail

The dangers of non-heart failure hospitalisation for heart failure patients: frequent medication changes without follow up

Speaker: Ms E. O'Donoghue (Dublin, IE)

Thumbnail

Clinical, echocardiographic and cost improvement after the onset with sacubitril-valsartan in mexican patients with heart failure.

Speaker: Doctor V. Gomez Leiva (San Salvador, SV)

Thumbnail

Access the full session

Poster Session 2 - Chronic Heart Failure – Treatment

Speakers: Doctor R. Pharithi, Doctor A. Ntalianis, Mr J. AGOSTINHO, Doctor F. Ferreira, Ms E. O'Donoghue...
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb